Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review

M Sharifian-Dorche, M Bahmanyar… - Journal of the …, 2021 - Elsevier
Introduction The common reported adverse effects of COVID-19 vaccination consist of the
injection site's local reaction followed by several non-specific flu-like symptoms. However …

Dissolvable polymer microneedles for drug delivery and diagnostics

M Ali, S Namjoshi, HAE Benson, Y Mohammed… - Journal of Controlled …, 2022 - Elsevier
Dissolvable transdermal microneedles (μND) are promising micro-devices used to transport
a wide selection of active compounds into the skin. To provide an effective therapeutic …

Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia

A Greinacher, K Selleng, R Palankar… - Blood, The Journal …, 2021 - ashpublications.org
Abstract SARS-CoV-2 vaccine ChAdOx1 nCoV-19 (AstraZeneca) causes a thromboembolic
complication termed vaccine-induced immune thrombotic thrombocytopenia (VITT). Using …

Adverse effects following COVID-19 vaccination in Iran

E Babaee, A Amirkafi, A Tehrani-Banihashemi… - BMC Infectious …, 2022 - Springer
Background Vaccination is a key intervention to prevent COVID-19. Many vaccines are
administered globally, yet there is not much evidence regarding their safety and adverse …

What is the extent of COVID-19 vaccine hesitancy in Bangladesh? A cross-sectional rapid national survey

M Ali, A Hossain - BMJ open, 2021 - bmjopen.bmj.com
Objectives To assess COVID-19 vaccine hesitancy in Bangladesh and identify population
subgroups with higher odds of vaccine hesitancy. Design A nationally representative cross …

Cardiovascular and haematological events post COVID‐19 vaccination: A systematic review

D Al‐Ali, A Elshafeey, M Mushannen… - Journal of cellular …, 2022 - Wiley Online Library
Since COVID‐19 took a strong hold around the globe causing considerable morbidity and
mortality, a lot of effort was dedicated to manufacturing effective vaccines against SARS …

Cerebral venous sinus thrombosis and thrombotic events after vector-based COVID-19 vaccines: a systematic review and meta-analysis

L Palaiodimou, MI Stefanou, AH Katsanos… - Neurology, 2021 - AAN Enterprises
Background and Objectives There is accumulating evidence supporting an association
between the thrombosis and thrombocytopenia syndrome (TTS) and adenovirus vector …

[HTML][HTML] Safety and reactogenicity of the ChAdOx1 (AZD1222) COVID-19 vaccine in Saudi Arabia

S Al Bahrani, A Albarrak, OA Alghamdi… - International Journal of …, 2021 - Elsevier
Abstract Introduction The Kingdom of Saudi Arabia was one of the first countries to
implement a COVID-19 vaccination program. This study estimated the safety and …

Autoimmunity roots of the thrombotic events after COVID-19 vaccination

F Elrashdy, MM Tambuwala, SS Hassan, P Adadi… - Autoimmunity …, 2021 - Elsevier
Although vaccination represents the most promising way to stop or contain the coronavirus
disease 2019 (COVID-19) pandemic and safety and effectiveness of available vaccines …

Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems

S Shrestha, J Khatri, S Shakya, K Danekhu… - Drugs & Therapy …, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new
species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2 …